TrialScientific reports2016

Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer.

Nai-Jung Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.